Ipilimumab (Ipi) retreatment at 10 mg/kg in patients with metastatic melanoma previously treated in phase II trials Meeting Abstract
| Authors: | Neyns, B.; Weber, J. S.; Lebbé, C.; Maio, M.; Harmankaya, K.; Hamid, O.; O'Day, S.; Chin, K. M.; McDowell, D. O.; Cykowski, L.; McHenry, B.; Wolchok, J. D. |
| Abstract Title: | Ipilimumab (Ipi) retreatment at 10 mg/kg in patients with metastatic melanoma previously treated in phase II trials |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419602760 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.9059 |
| Notes: | Meeting Abstract: 9059 -- Source: Wos |
